P02.136. A randomized controlled trial for the use of qigong in the treatment of pre and mild essential hypertension

Park, J; Hong, Sang-hoon; Park, T; Liu, Y; Kim, J; Kim, T; Kim, A; Jung, So-Young; Park, H; Choi, Sun Mi

doi:10.1186/1472-6882-12-s1-p192

Cited by 6 publications

(10 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Of the 106 potentially relevant studies that were identified, 46 were excluded for not completing an RCT or for producing irrelevant outcomes. Thus, we included 4311 patients with chronic diseases from the 60 remaining articles 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 (21 articles focused on musculoskeletal disorders, 16 articles focused on cardiovascular diseases, 14 articles focused on diabetes, 4 articles focused on cancers, 4 articles focused on chronic respiratory diseases, and 1 article focused on chronic physical illnesses). These articles were mainly published in China (n = 21, 35%), USA (n = 15, 25%), Australia (n = 4, 6.67%), Sweden (n = 3, 5%), Korea (n = 3, 5%), Hong Kong (n = 3, 5%), the UK (n = 2, 3.33%), Canada (n = 2, 3.33%), Germany (n = 2, 3.33%), New Zealand (n = 1, 1.67%), Israel (n = 1, 1.67%), and Japan (n = 1, 1.67%).…”

Section: Resultsmentioning

confidence: 99%

“…Using a random effects model, the meta-analysis of six studies 35 39 49 62 67 76 with 591 patients showed that TCE could improve the total SF-36 score in the short term [SMD (95% CI) = 0.59 (0.32, 0.87), P < 0.001] ( Table 3 ) and mid term [SMD (95% CI) = 0.61 (0.16, 1.05), P = 0.008] ( Table 3 ). The meta-analysis of 22 studies with 1533 patients 26 27 29 34 35 41 44 46 49 51 52 54 55 56 58 59 63 64 65 76 78 79 that were suitable for inclusion showed that TCE had a significant positive effect on the SF-36 physical function subscale in the short term [SMD (95% CI) = 0.35 (0.13, 0.56), P = 0.002] ( Table 3 and Fig. 2 ) and mid term [SMD (95% CI) = 0.49 (0.12, 0.85), P = 0.009] ( Table 3 and Fig.…”

Section: Resultsmentioning

confidence: 99%

“…3 ). A total of 22 studies with 1502 patients 20 27 29 34 35 42 44 46 49 51 52 54 55 56 58 59 63 64 65 76 78 79 were included to estimate the effect of TCE on the SF-36 mental health subscale. The TCE group outperformed the control group in terms of the SF-36 mental health subscale in the short term ([SMD (95% CI) = 0.28 (0.11, 0.46), P = 0.002) ( Table 3 , Supplementary Figure S1 ) and mid term [SMD (95% CI) = 0.39 (0.08, 0.71), P = 0.02] ( Table 3 , Supplementary Figure S2 ).…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Effect of traditional Chinese exercise on the quality of life and depression for chronic diseases: a meta-analysis of randomised trials

Wang

Chen

et al. 2015

Sci Rep

View full text Add to dashboard Cite

Traditional Chinese exercise (TCE) has many uses in the prevention and treatment of chronic diseases. However, there is no consensus regarding the benefit of TCE for chronic diseases. Our objective is to examine the effect of TCE on the quality of life and depression for chronic diseases by performing a meta-analysis of randomized controlled trials (RCTs). We only cover published RCTs. The outcome measures included quality of life and depression. Sixty articles with a total of 4311 patients were included. The pooling revealed that TCE could improve the SF-36 physical function subscale in the short term [SMD (95% CI) = 0.35 (0.13, 0.56), P = 0.002] and mid-term [SMD (95% CI) = 0.49 (0.12, 0.85), P = 0.009], GHQ [SMD (95% CI) = −0.68 (−1.26, −0.09), P = 0.02], the Center for Epidemiologic Studies depression scale in the short term [SMD (95% CI) = −0.86 (−1.42, −0.31), P = 0.002] and mid-term [SMD (95% CI) = −0.41 (−0.64, −0.18), P < 0.001]. The meta-analysis of RCT demonstrates that TCE can significantly improve the quality of life and depression of patients with chronic diseases. These findings provide useful information for patients with chronic diseases as well as for medical staff.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Effect of traditional Chinese exercise on the quality of life and depression for chronic diseases: a meta-analysis of randomised trials

Wang

Chen

et al. 2015

Sci Rep

View full text Add to dashboard Cite

show abstract

“…In previous studies, Tai chi, which is Chinese conditioning exercise focusing on graceful movement like qigong [21], and Baduanjin exercise [22] also showed encouraging evidence for hypertension. The type of qigong used in previous studies for hypertension varied from seated qigong [18], Mawangdui Daoyinshu [23], Baduanjin [24], and qigong exercise [25]. Dongeui qigong used in this study was developed by consensus of qigong experts and literature review, but it could cause insignificant result if it is not suitable for hypertension.…”

Section: Discussionmentioning

confidence: 99%

“…Only a few previous studies investigated the effect of qigong on prehypertension or mild hypertension. One study reported a significant effect of qigong on prehypertension and mild hypertension [25]. Further studies targeting prehypertension and mild hypertension are required because control of blood pressure is required in these conditions.…”

Section: Discussionmentioning

confidence: 99%

The Effect of Dongeui Qigong for Prehypertension and Mild Essential Hypertension

Park

Kim

Jung

et al. 2017

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

Although several previous studies have reported the effect of qigong on lowering blood pressure, rigorous trials are lacking. Studies evaluating the effect of qigong on prehypertension are also scarce. This study aimed to assess the effect of qigong on prehypertension and mild hypertension. Participants with prehypertension or mild hypertension were randomized to the Dongeui qigong group or a nontreated control group. In the qigong group, Dongeui qigong was administered 5 times/week for 12 weeks. The control group did not receive any intervention for blood pressure control. Fifty-two participants were included in this study. Even though diastolic blood pressure was significantly reduced in the qigong group after 8 weeks (p = 0.04) compared to baseline, the difference in change in blood pressure between the qigong and control groups was not significant. There were no significant differences in quality of life between the qigong and control groups. Dongeui qigong is not significantly effective in pre/mild hypertension compared with controls. This result could be due to a lack of effect of qigong or caused by other factors, such as the type of qigong, target symptoms, inappropriate sample size, and compliance of participants. Trial Registration. This trial is registered with KCT0001397 (Clinical Research Information Service).

show abstract

Moxibustion for prehypertension and stage I hypertension: a pilot randomized controlled trial

Shin

Park

Yook

et al. 2019

Integrative Medicine Research

View full text Add to dashboard Cite

BackgroundPrehypertension and hypertension are associated with cardiovascular disease, ischemic heart disease, and stroke morbidity. The purpose of this study is to evaluate the effectiveness and safety of moxibustion in patients with prehypertension or hypertension.MethodsForty-five subjects with prehypertension or stage I hypertension were randomized into three groups: moxibustion treatment group A (2 sessions/week for 4 weeks), moxibustion treatment group B (3 sessions/week for 4 weeks), and control group (nontreated group). The primary outcome measure was the change in blood pressure after 4 weeks of treatment. Safety was assessed at every visit.ResultsThere were no significant differences in systolic blood pressure (SBP) or diastolic blood pressure (DBP) among three groups after 4 weeks of treatment (p = 0.4798 and p = 0.3252, respectively). In treatment group B, there was a significant decrease in SBP and DBP from baseline to 4 weeks of treatment (mean difference (MD) −9.55; p = 0.0225, MD −7.55; p = 0.0098, respectively). There were no significant differences among groups in secondary outcome measures after 4 weeks of treatment. Six adverse events (AEs) in the treatment group A and 12 AEs in the treatment group B occurred related to the moxibustion treatment.ConclusionIn conclusion, the results of this study show that moxibustion (3 sessions/week for 4 weeks) might lower blood pressure in patients with prehypertension or stage I hypertension and treatment frequency might affect effectiveness of moxibustion in BP regulation. Further randomized controlled trials with a large sample size on prehypertension and hypertension should be conducted.Trial registrationThis study was registered with the ‘Clinical Research Information Service (CRIS)’, Republic of Korea (KCT0000469), and the protocol for this study was presented orally at the 15th International Council of Medical Acupuncture and Related Techniques (ICMART) in Athens, 25–27 May 2012.

show abstract

P02.136. A randomized controlled trial for the use of qigong in the treatment of pre and mild essential hypertension

Cited by 6 publications

References 0 publications

Effect of traditional Chinese exercise on the quality of life and depression for chronic diseases: a meta-analysis of randomised trials

Effect of traditional Chinese exercise on the quality of life and depression for chronic diseases: a meta-analysis of randomised trials

The Effect of Dongeui Qigong for Prehypertension and Mild Essential Hypertension

Moxibustion for prehypertension and stage I hypertension: a pilot randomized controlled trial

Contact Info

Product

Resources

About